-
Pharma Stocks Rally Despite Trump’s 200% Tariff Threat; Lupin, Biocon Top Gainers
09 Jul 2025 06:02 GMT
… 9:25 a.m. Lupin, Biocon, Aurobindo Pharma, and Laurus Labs … ’s 200% Tariff Threat; Lupin, Biocon Top Gainers
Disclaimer: Comments reflect …
-
From Laurus Labs, Lupin to Biocon— Pharma stocks rise up to 3% despite Trump's 200% tariff threat
09 Jul 2025 05:13 GMT
… stocks, including Laurus Labs, Lupin, Biocon, Cipla and Divi's …
-
Biocon to announce Q1 FY26 results on August 7
08 Jul 2025 20:30 GMT
Biocon Limited has informed stock exchanges … for Prevention of Insider Trading, Biocon has closed its trading window … within 5 working days on Biocon’s investor relations website
The …
-
Who will win India’s weight loss drug war: Wegovy, Mounjaro or Biocon?
07 Jul 2025 19:36 GMT
… Wegovy and Mounjaro already here, Biocon is quietly planning a global …
-
Two Biocon Biologics Denosumab Biosimilars Approved by MHRA
07 Jul 2025 18:58 GMT
… The denosumab biosimilars mark Biocon’s third and fourth … UK biosimilars market
For Biocon Biologics, the marketing … 5).
References
1. Biocon Biologics. Biocon Biologics Receives MHRA UK … 7, 2025.
5. Biocon Biologics. Biocon Biologics Receives MHRA Approval …
-
Biocon Biologics receives MHRA UK approval
07 Jul 2025 15:43 GMT
… biosimilars company and subsidiary of Biocon, has announced that the Medicines … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their …
-
Biocon Biologics gets UK’s MHRA approval for Denosumab biosimilars
07 Jul 2025 10:20 GMT
… 02:57 PM
New Delhi: Biocon Ltd on Monday said its … arm Biocon Biologics Ltd has received … advanced malignancies involving bone, Biocon said in a regulatory filing … increased risk of fractures. Biocon Biologics was recently granted marketing …
-
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy
07 Jul 2025 09:41 GMT
… Monday said its arm Biocon Biologics Ltd has received marketing … with advanced malignancies involving bone, Biocon said in a regulatory filing … at increased risk of fractures.
Biocon Biologics was recently granted marketing …
-
Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars
07 Jul 2025 09:28 GMT
… company and subsidiary of Biocon Ltd., today announced that … recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing …
Source : Equity Bulls
Keywords
Biocon
INE376G01013
Biotechnology
BioconBiologics
UKMHRA
Approval …
-
Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy
07 Jul 2025 08:13 GMT
… biosimilars company and subsidiary of Biocon Ltd., has received marketing authorisations … ) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their … giant cell tumour of bone
Biocon Limited, publicly listed in 2004 …